Zheng Quan Shi Bao·2025-09-07 22:27Group 1 - Company Xiangrikui is planning to acquire controlling stakes in Zhangzhou Xipu Materials Technology Co., Ltd. and 40% of Zhejiang Beid Pharmaceutical Co., Ltd. through share issuance and/or cash payment [2] - The transaction is expected to constitute a major asset restructuring, but it will not lead to a change in the actual controller of the company and does not constitute a restructuring listing [2][4] - A transaction intention agreement has been signed by all parties involved, and the company's stock was suspended from trading starting September 8 [4] Group 2 - Company *ST Bosen plans to sell 35% of its stake in Shaanxi Bosen Apparel Intelligent Manufacturing Co., Ltd. to Nantong Erfang Machine, which is expected to constitute a major asset restructuring [6] - This transaction does not involve share issuance, will not lead to a change in the controlling shareholder or actual controller, and is still in the preliminary planning stage [6] - The company reported a significant decline in operating performance, with a revenue of 51.95 million yuan and a net loss of 10.46 million yuan for the first half of 2025 [7]